Joen Johansen

President & CEO

MDC Associates Inc

Feb 2019 - Current (7 years 5 months)

MDC Associates is a full-service RA/QA/CRO offering, regulatory, clinical research, quality systems and technical support services to in vitro diagnostics (IVD) and medical device companies.

Interim Head of Scientific Affairs

Accelerate Diagnostics

Nov 2016 - Sep 2017 (11 months)

Responsible for analytical performance and Health-Economic Outcomes Research (HEOR) studies, scientific publications and presentations, clinical and scientific advisory boards, and KOL engagement.

Head of Strategic Marketing

Accelerate Diagnostics

Jan 2016 - Jan 2018 (2 years 1 month)

NASDAQ listed (AXDX - $1b+ market cap) rapid infectious diseases diagnostic company with 250+ employees. Reporting to President and CEO and responsible for corporate strategy, product management, and marketing communications. Charged with global launch of the Accelerate Pheno(TM) system and Accelerate PhenoTest(TM) BC kit for rapid Identification (ID) and Antimicrobial Susceptibility Testing (AST) for pathogens causing critical infection and sepsis in hospitalized patients.

Head of Global Marketing

Accelerate Diagnostics

Jan 2014 - Jan 2016 (2 years 1 month)

Reporting to Chief Commercial Officer and charged with introducing company and technology, and creating broad awareness of product solutions to key customer buying influencers (i.e. microbiology lab, infectious diseases, pharmacy). Also responsible for building strategic and tactical marketing infrastructure ahead of global product launch.

Managing Director

ClinicalValues

Jul 2012 - Dec 2013 (1 year 6 months)

Data, strategic marketing and business development consulting for startup diagnostic and medical device companies. 10 projects for 8 US and EU clients.

Director of Marketing

AdvanDx

Jan 2008 - Jun 2012 (4 years 6 months)

Private, VC backed company (50 employees - Acquired by OpGen in 2015) focused on development and commercialization of PNA-based molecular diagnostic tests for rapid identification of pathogens causing critical infections and sepsis. First-to-market (FDA 510k cleared) direct from blood culture pathogen ID tests demonstrated to improve patient outcomes and reduce hospital costs. Reporting to President & CEO and responsible for product strategy, product management, marketing communications and clinical market development activities.

Product Manager

AdvanDx

Jul 2004 - Dec 2007 (3 years 6 months)

Reporting to Vice President, Sales & Marketing and responsible for PNA FISH® product management and marketing communications activities. Focused on new product launches and supporting sales activities via lead generation, sales training, customer visits and customer presentations.

Sales Representative

AdvanDx

Feb 2003 - Jun 2004 (1 year 5 months)

Responsible for launching initial PNA FISH® tests in the United States

Consultant

ChemoCentryx

Sep 2001 - Jan 2003 (1 year 5 months)

Reporting to Head of Business Development built database of worldwide chemokine therapeutic development programs and intellectual property used to evaluate internal pipeline and assess corporate partnerships.

Investment Banking Analyst

Lehman Brothers

Jul 2000 - Aug 2001 (1 year 2 months)

Supported team of multi-national investment bankers on M&A and financing assignments for European healthcare clients.

About

Detail

Timeline

Résumé